Merck & Co., Inc. (6MK.DE) XETRA

72.90

+0.2(+0.28%)

Updated at September 12 02:16PM

Currency In EUR

Merck & Co., Inc.

Address

2000 Galloping Hill Road

Rahway, NJ 07033

United States of America

Phone

908 740 4000

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

73000

First IPO Date

December 28, 2007

Key Executives

NameTitlePayYear Born
Mr. Robert M. Davis J.D.Chairman, President & Chief Executive Officer4.42M1967
Mr. Richard R. DeLuca Jr.Executive Vice President & President of Merck Animal Health1.94M1963
Ms. Betty D. LarsonExecutive Vice President & Chief Human Resources Officer2.05M1976
Ms. Caroline LitchfieldExecutive Vice President & Chief Financial Officer2.37M1969
Ms. Jennifer L. Zachary J.D.Executive Vice President & General Counsel2.44M1978
Dr. Dean Y. Li M.D., Ph.D.Executive Vice President & President of Merck Research Laboratories2.93M1963
Mr. David Michael WilliamsExecutive Vice President and Chief Information & Digital Officer01969
Mr. Dalton E. Smart IIISenior Vice President of Finance, Principal Accounting Officer & Global Controller01967
Ms. Cristal N. DowningExecutive Vice President and Chief Communications & Public Affairs Officer01969
Mr. Peter DannenbaumVice President of Investor Relations0N/A

Description

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.